Munkhaugen J, Bakken A, Kristiansen AMD, Edvardsen T, Wiseth R, Steigen TK, Schirmer H, Larsen AI, Jortveit J, Vikenes K, Halvorsen S, Atar D (2026)
Secondary prevention with beta-blockers after myocardial infarction
Tidsskr Nor Laegeforen, 146 (2)
DOI 10.4045/tidsskr.25.0735, PubMed 41670311

Ueland T, Andersen GØ, Varathalingam S, Khan Y, Holm S, Limalanathan S, Hoffmann P, Michelsen AE, Broch K, Aukrust P, Gullestad L, Halvorsen B (2026)
Circulating B-cell activating factor in acute coronary syndromes - association with adverse outcomes and progression of heart failure
Atherosclerosis, 414, 120642 (in press)
DOI 10.1016/j.atherosclerosis.2026.120642, PubMed 41570405

Atar D, Munkhaugen J, Prescott EIB, Jernberg T, Ibáñez B (2026)
The use of β-blockers after myocardial infarction: no doubts remain
Nat Rev Cardiol (in press)
DOI 10.1038/s41569-026-01252-4, PubMed 41555043